ClinicalTrials.Veeva

Menu

NGS Assessment of Congenitally Deafned Children and Neonatal Deafness Screnning (GHELP)

U

University of Navarra

Status

Unknown

Conditions

Suspicion of Congenital Deafness
Congenital Deafness

Treatments

Other: Genetic screening. No therapeutic intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To assess the diagnostic value of NGS screnning in prelingually deafned children using a new designed chip, and to evaluate its interest in a the neonatal screening program for ddetecting congenitally deafned children.

Full description

The aim of the study is to evaluate the diagnostic value of a new panel of gene in NGS study in children presenting :

  1. A congenitally deafness : it is a retrospective study in children aged 0 to 17 yrs with hearing thresholds over 40 dB in the best ear using adapted audiometric assessment,
  2. A suspicion of deafness in babies aged 0 to 6 months having an abnormal response after otoacoustic emissions and automated ABR assessment.

The main outcomes studied will be the finding of a pathogenic mutation (or several mutations).

Enrollment

220 estimated patients

Sex

All

Ages

Under 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Retropective study

Inclusion criteria:

  • Age of onset of deafness between 0 and 17 years
  • With a hearing loss of one or two senses with, on the ear most affected, a hearing loss more than 40 dB in mean audiometric loss in behavioural audiometry
  • Availability of detailed information in Appendix 1: History, history and course of disease, associated symptoms, otoscopy data, radiology, treatments and hearing aids implemented.
  • Availability of DNA samples stored in an existing collection.
  • Consent to participate in the study (non-opposition) by the legal representative

Exclusion criteria

  • Exclusion criteria:

    • Child with a known cause of observed deafness (meningitis, post-surgery or drug iatrogenic, trauma, infections, tumor)
    • Family not willing to participate in the study

Prospective study

Inclusion criteria:

  • Age of the child 0 to 6 months including corrected age having had on at least one of the two ears a lack of acoustic otoemissions and a lack of response in automated PEA, and a threshold of PEA at least on one ear at more than 40 dB.
  • Availability of detailed information in Appendix 2: Personal history, family history of deafness, associated symptoms, tympanometry, otoscopy data, neonatal deafness test data.
  • Collection of the consent of the legal representative

Exclusion criteria:

· Family not willing to participate in the study

Trial design

220 participants in 1 patient group

Genetic study in retrospective and prospective groups
Description:
Genetic screening using NGS technique in a retrospective and prospective groups. No therapeutic intervention
Treatment:
Other: Genetic screening. No therapeutic intervention

Trial contacts and locations

1

Loading...

Central trial contact

Manuel Jesús M Manrique Rodriguez, ENT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems